The strategic value MSLs offer to therapeutic areas is without question. Yet, tapping that value is dependent on how effective MSLs are in reaching, educating, and satisfying their physician targets. These efforts can offer a significant challenge considering the time constraints on today’s HCPs/KOLs. It is, therefore, not surprising that a recent global survey by First Word … [Read more...]
Leveraging Medical Science Liaisons To Optimize Clinical Trials
Clinical trials consume a significant portion of the pharmaceutical industry’s research budget at approximately $78billion/year. Yet 80% of these clinical trials are delayed or closed due to issues with recruitment, with 37% of sites under-enrolling volunteers and 11% failing to enroll even one patient.1 The problem is staggering in terms of absolute financial and human costs. … [Read more...]